Press releases
- Personalis to Announce Second Quarter 2024 Financial Results
- Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference
- Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call
- ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
- Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus
- Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024
- Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Personalis Reports First Quarter 2024 Financial Results
More ▼
Key statistics
On Wednesday, Personalis Inc (04X:FRA) closed at 2.53, -25.35% below its 52-week high of 3.39, set on Jul 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.53 |
---|---|
High | 2.53 |
Low | 2.53 |
Bid | -- |
Offer | -- |
Previous close | 2.53 |
Average volume | 3.13k |
---|---|
Shares outstanding | 51.94m |
Free float | 42.16m |
P/E (TTM) | -- |
Market cap | 149.58m USD |
EPS (TTM) | -1.89 USD |
Data delayed at least 15 minutes, as of Jul 24 2024 07:06 BST.
More ▼